Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360-degree synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic and blood-related disorders
3.2.1.2 Growing demand for blood transfusions
3.2.1.3 Rise in awareness regarding blood donations and platelets transfusions
3.2.1.4 Rising number of surgical procedures
3.2.2 Industry pitfalls & challenges
3.2.2.1 High risk of transmissions of infections
3.2.2.2 High cost of the treatment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Reimbursement scenario
3.7 Pricing analysis, by region, 2021-2032
3.7.1 North America
3.7.1.1 U.S.
3.7.1.2 Canada
3.7.2 Europe
3.7.2.1 Germany
3.7.2.2 UK
3.7.2.3 France
3.7.2.4 Spain
3.7.2.5 Italy
3.7.3 Asia Pacific
3.7.3.1 China
3.7.3.2 Japan
3.7.3.3 India
3.7.3.4 Australia
3.7.3.5 South Korea
3.7.4 Latin America
3.7.4.1 Brazil
3.7.4.2 Mexico
3.7.4.3 Argentina
3.7.5 MEA
3.7.5.1 South Africa
3.7.5.2 Saudi Arabia
3.7.5.3 UAE
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Future market trends
3.11 Gap analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Competitive positioning matrix
4.3 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Platelet Type, 2021 – 2032 ($ Mn & Units)
5.1 Key trends
5.2 Apheresis derived platelets
5.3 Whole blood derived platelet
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Thrombocytopenia
6.3 Hemato-oncology
6.4 Perioperative indications
6.5 Hemophilia
6.6 Platelet function disorders
6.7 Other applications
Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 American Association of Blood Banks (AABB)
9.2 American National Red Cross
9.3 America's Blood Centers
9.4 Blood Centers of America
9.5 Brazilian Red Cross
9.6 Canada Blood Services
9.7 French Red Cross
9.8 German Red Cross
9.9 Indian Red Cross Society
9.10 Italian Red Cross
9.11 Japanese Red Cross Society
9.12 OneBlood
9.13 Red Cross Society of China
9.14 South African Red Cross
9.15 Spanish Red Cross
9.16 The European Blood Alliance (EBA)
